• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

区域淋巴结浸润和增厚病变与高危切除黑色素瘤的预后不良相关:一项回顾性队列研究。

Regional lymph node infiltration and thick lesions are associated with poor prognosis in high-risk resected melanomas: A retrospective cohort study.

作者信息

Anwar Sumadi Lukman, Cahyono Roby, Budiman Heru Yudanto, Avanti Widya Surya, Harahap Wirsma Arif, Aryandono Teguh

机构信息

Division of Surgical Oncology - Department of Surgery, Dr Sardjito Hospital / Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.

Department of Radiology, Dr Sardjito Hospital / Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.

出版信息

Ann Med Surg (Lond). 2020 Dec 16;61:132-138. doi: 10.1016/j.amsu.2020.12.004. eCollection 2021 Jan.

DOI:10.1016/j.amsu.2020.12.004
PMID:33456772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7797471/
Abstract

BACKGROUND

Acral lentiginous and mucosal melanoma that represent lesions without cumulative sun-induced damages account for 65% of melanomas among Asians but constitute only 5% in Caucasians. The distinct clinical manifestations might influence the clinical course, response to treatment, and outcomes. Factors associated with the prognosis of high-risk resected melanoma in Asians are still rarely reported.

METHODS

Clinical, histological determinants of non-distant metastatic melanoma patients who underwent complete resection in 2014-9 were analyzed.

RESULTS

Mucosal melanoma, nodular melanoma, and acral lentiginous melanoma accounted for 45.1%, 40.2%, and 14.2% of total melanoma cases (N = 82), respectively. Among cutaneous melanomas, all patients were diagnosed with Breslow's depth more than 4 mm (T4), 51% with ulceration, 95.6% with diameter more than 6 mm, 59% with lympho-vascular invasion, and 74% with regional lymph node infiltration. In mucosal melanomas, 78.3% were diagnosed in advanced stages, 14.5% with regional spread to lymph nodes and 77% with regional infiltration beyond mucosa. Lesions with ulceration were associated with higher risk of distant metastasis (OR 3.003, 95%CI:1.01-9.09). Infiltration into regional lymph node was associated with shorter overall survival (median survivals were 17 vs 23.4 months, Mantel-Cox test  = 0.049). Patients diagnosed at Breslow T4 were also associated with poorer overall survival than T1-3 (median survivals were 23 vs 32 months, Mantel-Cox test  = 0.047).

CONCLUSION

The majority of melanoma patients in our population were diagnosed in advanced stages with a higher risk for recurrence and progression into distant metastasis. Regional lymph node involvement and thicker tumor (T4) were associated with poor prognosis.

摘要

背景

肢端雀斑样痣型和黏膜黑色素瘤代表无累积日光诱导损伤的病变,在亚洲人中占黑色素瘤的65%,而在白种人中仅占5%。不同的临床表现可能会影响临床病程、对治疗的反应及预后。关于亚洲高危切除黑色素瘤预后相关因素的报道仍然很少。

方法

分析2014年至2019年接受根治性切除的非远处转移性黑色素瘤患者的临床和组织学决定因素。

结果

黏膜黑色素瘤、结节性黑色素瘤和肢端雀斑样痣型黑色素瘤分别占黑色素瘤总病例数(N = 82)的45.1%、40.2%和14.2%。在皮肤黑色素瘤患者中,所有患者均诊断为Breslow深度超过4mm(T4),51%有溃疡,95.6%直径超过6mm,59%有淋巴管浸润,74%有区域淋巴结浸润。在黏膜黑色素瘤中,78.3%诊断为晚期,14.5%有区域淋巴结转移,77%有黏膜外区域浸润。有溃疡的病变远处转移风险更高(OR 3.003,95%CI:1.01 - 9.09)。区域淋巴结浸润与总生存期缩短相关(中位生存期分别为17个月和23.4个月,Mantel - Cox检验 = 0.049)。诊断为Breslow T4的患者总生存期也比T1 - 3患者差(中位生存期分别为23个月和32个月,Mantel - Cox检验 = 0.047)。

结论

我们研究人群中的大多数黑色素瘤患者诊断为晚期,复发和远处转移进展风险较高。区域淋巴结受累和肿瘤较厚(T4)与预后不良相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3195/7797471/9624aa030fb2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3195/7797471/9624aa030fb2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3195/7797471/9624aa030fb2/gr1.jpg

相似文献

1
Regional lymph node infiltration and thick lesions are associated with poor prognosis in high-risk resected melanomas: A retrospective cohort study.区域淋巴结浸润和增厚病变与高危切除黑色素瘤的预后不良相关:一项回顾性队列研究。
Ann Med Surg (Lond). 2020 Dec 16;61:132-138. doi: 10.1016/j.amsu.2020.12.004. eCollection 2021 Jan.
2
Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures.黑色素瘤前哨淋巴结活检:234例连续手术经验
Plast Reconstr Surg. 2000 May;105(6):1956-66. doi: 10.1097/00006534-200005000-00007.
3
Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.前哨淋巴结微转移及其他组织学因素对较厚黑色素瘤患者预后的预测作用
J Am Acad Dermatol. 2001 May;44(5):762-6. doi: 10.1067/mjd.2001.112346.
4
Prognostic value of sentinel lymph node biopsy in melanomas of different Breslow's thickness.前哨淋巴结活检在不同Breslow厚度黑色素瘤中的预后价值。
Swiss Med Wkly. 2016 Sep 29;146:w14358. doi: 10.4414/smw.2016.14358. eCollection 2016.
5
Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?T1期(薄型)黑色素瘤的前哨淋巴结活检:有必要吗?
Ann Plast Surg. 2003 Jun;50(6):601-6. doi: 10.1097/01.SAP.0000069065.00486.1E.
6
Time-varying pattern of recurrence risk for localized melanoma in China.中国局限性黑色素瘤复发风险的时变模式。
World J Surg Oncol. 2020 Jan 4;18(1):6. doi: 10.1186/s12957-019-1775-5.
7
Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.基于证据和多学科共识的德国黑色素瘤诊疗指南:黑色素瘤的诊断与监测
Melanoma Res. 2007 Dec;17(6):393-9. doi: 10.1097/CMR.0b013e3282f05039.
8
Surgical management of primary cutaneous melanomas of the hands and feet.手足原发性皮肤黑色素瘤的外科治疗
Ann Surg. 1997 May;225(5):544-50; discussion 550-3. doi: 10.1097/00000658-199705000-00011.
9
Differences by Anatomical Site of Non-Acral Lentiginous Melanomas of the Lower Limb.下肢非肢端雀斑样黑素瘤的解剖部位差异。
Dermatology. 2022;238(5):977-985. doi: 10.1159/000522492. Epub 2022 Mar 29.
10
Melanoma in Singapore: A 20-year review of disease and treatment outcomes.新加坡的黑色素瘤:疾病与治疗结果的20年回顾。
Ann Acad Med Singap. 2021 Jun;50(6):456-466. doi: 10.47102/annals-acadmedsg.2020535.

引用本文的文献

1
BRAF and NRAS Mutations and the Association with Prognosis of Acral Lentiginous and Nodular Melanomas in Indonesia.BRAF 和 NRAS 突变与印度尼西亚肢端雀斑样和结节性黑色素瘤预后的关系。
Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3525-3531. doi: 10.31557/APJCP.2024.25.10.3525.
2
The prioritation and gap of preoperative COVID-19 vaccination in cancer surgery of the breast, head and neck, and skin: A cohort study of 367 patients in an Indonesian hospital.乳腺癌、头颈癌和皮肤癌手术中术前新冠病毒疫苗接种的优先级及差距:对一家印度尼西亚医院367例患者的队列研究
Ann Med Surg (Lond). 2021 Dec;72:103089. doi: 10.1016/j.amsu.2021.103089. Epub 2021 Nov 18.
3

本文引用的文献

1
Clinical characteristics and the associated risk factors of the development of bilateral breast cancers: A case-control study.双侧乳腺癌发生的临床特征及相关危险因素:一项病例对照研究。
Ann Med Surg (Lond). 2020 Nov 4;60:285-292. doi: 10.1016/j.amsu.2020.10.064. eCollection 2020 Dec.
2
Case report: Neoadjuvant systemic therapy for melanoma.
Ann Med Surg (Lond). 2020 May 25;55:177-179. doi: 10.1016/j.amsu.2020.05.013. eCollection 2020 Jul.
3
Risk factors of distant metastasis after surgery among different breast cancer subtypes: a hospital-based study in Indonesia.不同乳腺癌亚型手术后远处转移的危险因素:印度尼西亚的一项基于医院的研究。
Vigilance to misleading information is required to avoid delayed diagnosis: Case series of acral melanomas.
需要警惕误导性信息以避免延迟诊断:肢端黑色素瘤病例系列
Ann Med Surg (Lond). 2021 Apr 21;65:102270. doi: 10.1016/j.amsu.2021.102270. eCollection 2021 May.
World J Surg Oncol. 2020 May 30;18(1):117. doi: 10.1186/s12957-020-01893-w.
4
BRAF V600 mutation profiling in primary skin nodular melanoma in Indonesia: an analysis using high resolution pyrosequencing.印度尼西亚原发性皮肤结节性黑色素瘤中BRAF V600突变分析:一项使用高分辨率焦磷酸测序法的分析
BMC Res Notes. 2020 Mar 18;13(1):164. doi: 10.1186/s13104-020-05000-w.
5
Time-varying pattern of recurrence risk for localized melanoma in China.中国局限性黑色素瘤复发风险的时变模式。
World J Surg Oncol. 2020 Jan 4;18(1):6. doi: 10.1186/s12957-019-1775-5.
6
STROCSS 2019 Guideline: Strengthening the reporting of cohort studies in surgery.STROCSS 2019 指南:加强外科学队列研究报告。
Int J Surg. 2019 Dec;72:156-165. doi: 10.1016/j.ijsu.2019.11.002. Epub 2019 Nov 6.
7
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.皮肤黑色素瘤:ESMO 诊断、治疗及随访临床实践指南†
Ann Oncol. 2019 Dec 1;30(12):1884-1901. doi: 10.1093/annonc/mdz411.
8
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.新辅助全身治疗黑色素瘤:国际新辅助黑色素瘤联盟的建议。
Lancet Oncol. 2019 Jul;20(7):e378-e389. doi: 10.1016/S1470-2045(19)30332-8.
9
Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor.高危原发性肿瘤诊断后黑色素瘤复发的风险。
JAMA Dermatol. 2019 Jun 1;155(6):688-693. doi: 10.1001/jamadermatol.2019.0440.
10
The clinical significance of indeterminate pulmonary nodules in melanoma patients at baseline and during follow-up chest CT.黑色素瘤患者基线及随访胸部CT检查中肺内不确定结节的临床意义
Eur J Radiol Open. 2019 Feb 11;6:85-90. doi: 10.1016/j.ejro.2019.02.003. eCollection 2019.